top of page
Browse by category
Search
RefluxStop results in 90.9% reduction in GERD-HRQL score
German investigators have reported that the RefluxStop implantable device for the management of gastroesophageal reflux disease (GERD)...
Journal watch 18/09/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Key factors that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications
Weight reduction at one year is associated with the injectable semaglutide or liraglutide’s active agent, its dosage, treatment...
23 US states more than one in three adults has obesity
The latest CDC population data from 2023 show that in 23 states more than one in three adults (35%) has obesity. Before 2013, no state...
RefluxStop provides substantial clinical benefits for GERD patients with marginal budget impact on the health service
Introducing RefluxStop device (Implantica) as a treatment option for gastroesophageal reflux disease (GERD) patients treated within the...
Tirzepatide results in greater weight loss in women than men
All doses of tirzepatide consistently reduced body weight in women and men, but women experienced greater weight loss, according to post...
Browse by tag
bottom of page